- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
< Back to Bio
Dr. Salomé Cisnal de Ugarte
Dr. Salomé Cisnal de Ugarte
Events 6 results
Speaking Engagement
March 30, 2022
Dr. Salome Cisnal de Ugarte to Speak at Center for the Study of Financial Innovation Event
Speaking Engagement
March 28, 2022
Dr. Salome Cisnal de Ugarte to Speak on American Bar Association Antitrust Section Webinar
Webinar
February 9, 2022
Does the Digital Markets Act Increase Legal Risks for Non-Gatekeeper Platforms?
Speaking Engagement
December 9, 2021
Salomé Cisnal de Ugarte, Ivan Pico Toro to Speak on World Federation of Advertisers’ Digital Governance Exchange Virtual Meeting
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Speaking Engagement
September 24, 2021
Salomé Cisnal de Ugarte to Speak at LIDC Congress 2021